Company / Operating Cash Flow per Share
Innoviva, Inc. Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$3.14
FY2025
5-year range
$2.04 / $4.50
FY2021-FY2025
Trend
+5.4%
vs FY2024
Sector context
#33 of 212
Health Care
What the data says
Innoviva, Inc.'s operating cash flow per share of $3.14 is higher than 84% of companies in the Health Care sector (FY2025). Operating Cash Flow per Share has fluctuated over the past 10 years, ranging from $0.54 in FY2016 to $4.50 in FY2022.
Based on SEC 10-K filings.
3.14 in FY2025 with a 5-year CAGR of +0.3%. Top quartile in the Health Care sector.
Improved from $2.04 to $3.14 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -11.3%
- 5-Year CAGR
- +0.3%
- 10-Year CAGR
- -
Sector benchmark
-40.4% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 5.4% year-over-year.
- Ranks #33 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2022.
- Lowest operating cash flow per share in the period was in FY2016.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.14 | +5.4% |
| FY2024 | $2.98 | +46.2% |
| FY2023 | $2.04 | -54.7% |
| FY2022 | $4.50 | +25.4% |
| FY2021 | $3.59 | +16.1% |
| FY2020 | $3.09 | +120.5% |
| FY2019 | $1.40 | +132.4% |
| FY2018 | $0.60 | -50.9% |
| FY2017 | $1.23 | +125.8% |
| FY2016 | $0.54 | +450.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026